Author:
Lee James,Sadelain Michel,Brentjens Renier
Reference15 articles.
1. Onodera M, Ariga T, Kawamura N, Kobayashi I, Ohtsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity GJ, Blaese RM, Sakiyama Y. (1998) Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood. 91, 30Ð6
2. Palù G, Pira GLi, Gennari F, Fenoglio D, Parolin C and Manca F. (2001) Genetically modified immunocompetent cells in HIV infection. Gene Therapy. 21, 1593Ð1600
3. Nakajima A. (2006) Application of cellular gene therapy for rheumatoid arthritis. Mod Rheumatol. 5, 269Ð275
4. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 314, 126Ð129
5. Hwu P, Yannelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mule J, Rosenberg SA. (1993) Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans. J Immunol. 150, 4104Ð4115
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献